单克隆抗体精确疗法针对双相情感障碍的炎症:叙述性综述
1School of Clinical Pharmacy (School of integrative Pharmacy), Guangdong Pharmaceutical University, Guangzhou, China.
Therapeutic advances in psychopharmacology
|February 7, 2024
概括
双极性障碍 (BD) 可能与免疫炎症有关. 本综述探讨抗炎单克隆抗体作为潜在的BD精确疗法,检查其有效性和安全性.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 精神病学是一个精神病学.
背景情况:
- 双极性障碍 (BD) 的发病过程仍然很复杂,目前正在对炎症过程进行研究.
- 在BD患者中观察到炎症性细胞因子水平升高,这表明免疫失调的作用.
- 用抗炎单克隆抗体治疗自身免疫疾病的患者报告了精神症状,如抑郁和焦虑.
研究的目的:
- 要总结目前关于BD炎症细胞因子水平的研究.
- 评估抗炎单克隆抗体作为BD新治疗策略的潜力.
- 分析BD治疗的特定抗炎单克隆抗体的药理效应和临床试验数据.
主要方法:
- 对BD中细胞因子水平研究的综合文献综述.
- 在精神病学背景下对单克隆抗体药物 (例如,因弗力西马布,托西利祖马布,卡纳基努马布) 的临床试验数据的分析.
- 基于疗效,安全性和治疗潜力的抗炎单克隆抗体的分类 (I-IV级).
主要成果:
- 有证据表明,免疫炎症和BD之间存在相关性.
- 抗炎单克隆抗体显示出治疗BD和相关精神症状的潜力.
- 诸如因弗利西马布,托西利祖马布和卡纳基努马布之类的特定药物需要对BD进行进一步的研究.
结论:
- 免疫炎症是双相情感障碍的一个潜在因素.
- 抗炎单克隆抗体是个性化BD治疗的有希望的途径.
- 进一步的研究对于确定这些药物在精神病学中的药物效应和临床实用性至关重要.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
01:24Mania and Antimanic Drugs: Overview
181
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
181
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:30Bipolar Disorder
67
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166